Seizures are the presenting symptom in about 20% to 40% of patients with brain tumors and occur in about half of them during the course of the disease. Mixed gliomas, oligodendrogliomas and astrocytomas are most frequently associated with epilepsy. In patients with postoperative seizures neuroimaging should be performed to exclude tumor recurrence. We reported a case of 56-years old female admitted to our hospital with clinical signs of increased postoperative partial seizures activity and mild focal deficit. Medical history revealed that patient became symptomatic by brain tumor with sudden onset of generalized tonic-clonic seizure sixteen years ago. A low-grade astrocytoma was verified histologically after surgery. Ten years later the patient experienced right-sided partial motor and sensory seizures. Antiepileptic therapy was initiated and temporary good control of epilepsy was achieved. Current EEG findings showed left frontotemporal focus of epileptic activity. On contrast-enhanced CT scans no recurrent tumor mass was visualized. Brain SPECT images demonstrated no Tc-99m MIBI uptake. Despite the clinical presentation of refractory partial seizures, tumor recurrence was not detected. Based on the literature analysis and our own data, different etiological mechanisms underlying tumor-associated epilepsy were discussed.
INTRODUCTION
According to the literature, seizures occur in about half of patients with brain tumors during the course of the disease (2, 6, 8, 9, 13). They may be focal or generalized and clinical manifestation includes motor, sensory, visual or behavioral changes (16, 17, 18, 21, 23) . The seizures type and incidence depend on the location, size and the histology of the tumor. Tumors involving the frontal, frontoparietal, temporal and frontotemporal lobes are most commonly associated with occurrence of seizures (1, 2, 6, 8, 18 ). Previous studies report that patients with mixed gliomas, oligodendrogliomas and astrocytomas experience seizures most frequently (1, 12, 14, 24, 25) . Etiological mechanisms underlying tumor-associated epilepsy include cerebral edema, local metabolic imbalances, and changes in neuronal and glial enzyme expression, altered immunological activity etc. (6, 16, 17, 24) . In patients with postoperative seizures, particularly in the presence of therapeutic anticonvulsant level, neuroimaging should be performed to exclude tumor recurrence or hemorrhage (3, 4, 5, 7, 10, 11, 20).
CASE PRESENTATION
We reported a case of 56-years old female who experienced increased postoperative partial seizures activity within the last three months. Clinical examination found mild right-sided facial palsy, hemiparesis, hemihypestesia and cognitive deficit (MMSE -24 points). Past medical history revealed that patient became symptomatic by brain tumor 16 years ago, with sudden onset of generalized tonic-clonic seizure. Initial CT images visualized a tumor lesion in the left frontotemporal region. Surgery was performed and histological verification showed features of low-grade astrocytoma. Ten years after the operation the patient remained seizure free. Partial motor and sensory seizures with or without secondary generalization developed later. Electroencephalography (EEG) demonstrated an epileptic discharge in left frontotemporal region. CT scans follow-up showed no evidence of recurrent tumor. Antiepileptic therapy was initiated and temporary good control of epilepsy was achieved. Based on the medical history and clinical data, a possible tumor relapse was suggested. Current EEG findings showed left frontotemporal focus of epileptic activity (Fig.1) . On contrast-enhanced computed tomography (CT) scans no recurrent tumor mass appeared (Fig.2) . Brain single photon emission computed tomography (SPECT) images demonstrated no Tc-99m MIBI uptake (Fig.3) . Despite the clinical presentation of refractory partial seizures, no tumor recurrence was detected.
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There is increasing evidence that brain tumors are the second most common cause (6 -11 %) of epilepsy (13, 16, 17, 24) . Focal and/or generalized seizures may occur as an initial sign or a late onset in about 40% to 60% of patients (1, 15, 17, 19) . Their symptomatology depends on the localization, size and histology of the neoplastic lesion (16, 19, 24) .
Recent studies present data that seizures are associated most frequently with slow growing tumors, involving mixed gliomas (62%), oligodendrogliomas (53%) and astrocytomas (42%) (8, 13, 14, 16 ). Perirolandic cortex and medial temporal structures, followed by other areas of frontal, temporal and parietal lobes are considered to be the most epileptogenic (2, 6).
The literature analysis suggests that in patients with abrupt increase in frequency and severity of late postoperative seizures, despite therapeutic anticonvulsant levels, a structural change in tumor should be suspected (11, 26) . In these cases, CT scan or MRI and additional functional neuroimaging studies should be performed to identify a possible tumor recurrence or hemorrhage (5, 7, 8, 22, 24, 27, 29) . Patients' evaluation includes also clinical data and complimentary assessment of EEG findings (8, 9, 22, 27) . In accordance with these facts we performed also structural scans and brain SPECT. Although clinical signs and EEG findings in our patient were suspicious for tumor recurrence the neuroimaging results were negative, a fact that suggested another underlying epilepsy mechanisms.
According to the literature, the increased electrical activity of the neurons in a seizure focus can be due to altered properties of the neurons, altered synaptic connections between neurons, or altered conditions surrounding the neurons (2, 11, 18, 28). There is also evidence, however, that seizures in the setting of a brain tumor may be due to alterations in the brain tissue surrounding the tumor, rather than within the tumor. In addition, our data suggested that possible etiological mechanisms of tumor-associated epilepsy might be local metabolic imbalances, changes in neuronal and glial enzyme expression or altered immunological activity.
In conclusion, based on the literature analysis and our own past and present data we suggest that low-grade astrocytomas are among the most frequently brain tumors associated with epilepsy. Most commonly they are localized in the frontal and/or temporal regions and cause focal motor and/ or sensory seizures. Different etiological mechanisms underlying tumor associated-epilepsy are discussed including peritumoral amino acid disturbances, local metabolic imbalances, cerebral edema, pH abnormalities, changes in neuronal and glial protein expression and altered immunological activity. Although the mechanisms of tumor-related epileptogenesis remain unclear, in patients with postoperative seizures tumor relapse should be considered. Therefore, evaluation of clinical data, EEG findings, structural scans, pathological diagnosis and post-surgical follow-up is necessary. The more so as tumor-associated epilepsy has important clinical, social and economic implications. 
